Intelligence · Clinical Development
Pipeline search results
Programs matching “imatinib” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 12 pipeline programs matching "imatinib" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Imatinib
United Therapeutics Europe Ltd
Myeloid Leukemia, Chronic, Chronic Phase
1 trial -
Imatinib Mesylate Tablets, 400 mg
Amneal Pharma Europe Ltd
Chronic Myeloid Leukemia
1 trial -
CA180-226
Bristol-Myers Squibb Australia Pty Ltd
Children and Adolescents with Newly Diagnosed Chronic Phase CML or with Ph+ Leukemias Resistant to or Intolerant to Imatinib
1 trial -
CABL001E2201
Novartis Pharmaceuticals
Chronic Myelogenous Leukemia in chronic phase (CML-CP), previously treated with imatinib and have not achieved deep molecular response
1 trial -
Dream01, IMATINIB
Pari Pharma GmbH
SCD severe patients
1 trial -
Imatinib
The First People's Hospital of Lianyungang
Progression-free Survival
1 trial -
Imatinib Mesylate
United Therapeutics Europe Ltd
Pulmonary Arterial Hypertension
1 trial -
Imatinib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Solid Tumor Cancer
1 trial -
Imatinib Mesylate
Inhibikase Therapeutics
CML
1 trial -
Imatinib/Acetaminophen
Novartis Pharmaceuticals
Chronic Myeloid Leukemia (CML)
1 trial -
imatinib mesylate
Children's Hospital of Fudan University
Leukemia
1 trial -
IMATINIB for Chronic myeloid leukaemia
Disc Medicine
Chronic myeloid leukaemia
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.